SCHEMBL2863260

SCHEMBL2863260

CC(C)(C)OC(=O)n1nc(-c2cccc(F)c2)c2cc(CN)ccc21

nearest known ligand 0.58

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
MAP2K4 P45985 1/20 0.58
NR1H2 P55055 2/20 0.44
TAAR1 Q96RJ0 1/20 0.40
ICMT O60725 3/20 0.38
PTGER1 P34995 1/20 0.37
PDE4B Q07343 1/20 0.35
ELANE P08246 2/20 0.34
CSNK1D P48730 2/20 0.34
CSNK1E P49674 2/20 0.34
GPR119 Q8TDV5 1/20 0.34
SLC16A3 O15427 1/20 0.34
SLC16A1 P53985 1/20 0.34
MCTS1 Q9ULC4 1/20 0.34
LOXL2 Q9Y4K0 1/20 0.34
NR1H3 Q13133 1/20 0.33
RIPK2 O43353 1/20 0.33
MAPT P10636 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2858091 0.91 MAP2K4 (0.56) MAP2K4NR1H2ICMTPTGER1PDE4B
SCHEMBL2862273 0.90 MAP2K4 (0.55) MAP2K4NR1H2ICMTPTGER1PDE4B
SCHEMBL13198131 0.90 MAP2K4 (0.55) MAP2K4NR1H2ICMTPTGER1PDE4B
SCHEMBL2860870 0.87 MAP2K4 (0.61) MAP2K4NR1H2TAAR1ICMTPTGER1
SCHEMBL27538879 0.85 MAP2K4 (0.51) MAP2K4NR1H2ICMTPTGER1PDE4B
SCHEMBL2859046 0.84 TAAR1 (0.46) MAP2K4TAAR1ICMTPTGER1PDE4B
SCHEMBL2871497 0.84 NR1H2 (0.51) MAP2K4NR1H2NR1H3RIPK2
SCHEMBL2871097 0.83 MAP2K4 (0.56) MAP2K4NR1H2ICMTPTGER1PDE4B
SCHEMBL2864722 0.81 MAP2K4 (0.55) MAP2K4ELANEMAPT
SCHEMBL2861577 0.80 MAP2K4 (0.53) MAP2K4PTGER1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7776890-B2 1H-indazole compounds EISAI R&D MANAGEMENT CO., LTD. (JP) 2010-08-17 US disclosed
EP-1380576-B1 1H-INDAZOLE COMPOUNDS INHIBITING JNK EISAI R&D MAN CO LTD (JP) 2009-11-25 EP disclosed
US-20090203691-A1 Novel 1H-indazole compounds OINUMA HITOSHI 2009-08-13 US disclosed
US-7541376-B2 1H-indazole compounds EISAI R&D MANAGEMENT CO., LTD. (JP) 2009-06-02 US disclosed
CN-1300116-C 1H-indazole compounds EISAI CO LTD (JP) 2007-02-14 CN disclosed
US-6982274-B2 1H-indazole compound EISAI CO., LTD. (JP) 2006-01-03 US disclosed
US-20050282880-A1 Novel 1H-indazole compounds EISAI R&D MANAGEMENT CO., LTD. (JP) 2005-12-22 US disclosed
CN-1512987-A Novel 1H-indazole compound ������������ʽ���� 2004-07-14 CN disclosed
US-20040127538-A1 Novel 1h-indazole compound EISAI R&D MANAGEMENT CO., LTD. (JP) 2004-07-01 US disclosed
EP-1380576-A1 NOVEL 1H-INDAZOLE COMPOUND Eisai Co., Ltd. (JP) 2004-01-14 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090203691-A1 Novel 1H-indazole compounds MAPK1, MAPK3, MAPK13 MAP2K4 61/4885NR1H2 374/4885TAAR1 802/4885
US-20040127538-A1 Novel 1h-indazole compound MAPK1, MAPK14, MAPK3 MAP2K4 53/4885NR1H2 188/4885TAAR1 1627/4885
US-20050282880-A1 Novel 1H-indazole compounds MAPK1, MAPK3, MAPK13 MAP2K4 61/4885NR1H2 374/4885TAAR1 802/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.